Skip to content

Form 4 filed by Reardon Andrew

Reardon Andrew filed this Form 4 on LGND (LIGAND PHARMACEUTICALS INC) with 15 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-04 21:23:00 UTC.

Accession
0001950232-26-000006
Filed
2026-11-04
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: LGND · LIGAND PHARMACEUTICALS INC (CIK 886163)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-11-02M exercised+5,000$52.2736,854D
Common Stock 2026-11-02S sold-283$307.391736,571D
Common Stock 2026-11-02S sold-708$308.430835,863D
Common Stock 2026-11-02S sold-522$309.909735,341D
Common Stock 2026-11-02S sold-490$310.614934,851D
Common Stock 2026-11-02S sold-520$311.717834,331D
Common Stock 2026-11-02S sold-634$312.854333,697D
Common Stock 2026-11-02S sold-403$313.749233,294D
Common Stock 2026-11-02S sold-80$314.5833,214D
Common Stock 2026-11-02S sold-280$317.907132,934D
Common Stock 2026-11-02S sold-440$318.726532,494D
Common Stock 2026-11-02S sold-320$319.969832,174D
Common Stock 2026-11-02S sold-200$321.4431,974D
Common Stock 2026-11-02S sold-120$323.143331,854D
Employee Stock Option (right to buy) derivative2026-11-02M exercised-5,000$024,104D